Skip to content
lifestyle.californiaconsumerbanking.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Proscia
Femasys Regains Compliance with Nasdaq Listing Requirements
June 24, 2026
Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists
June 17, 2026
NextGen Pathology Selects Proscia to Establish AI Foundation for Business Growth
June 3, 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
May 13, 2026
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
May 11, 2026
Proscia Wins 2026 MedTech Breakthrough Award for Turning the Moment of Diagnosis into Drug Development Insights
May 9, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
May 7, 2026
Pathologie Friesland is Advancing Its Practice for Growth
May 6, 2026
Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings
April 29, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
April 24, 2026
1
2
Next Page
→